A rest-activity biomarker to predict response to SSRIs in major depressive disorder

Journal of Psychiatric Research

Volumn 64, Issue , 2015, Pages 19-22

  McCall, W Vaughn ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Actigraphy; Bathyphase; Circadian; Depression; Fluoxetine; Predictor

Indexed keywords

BIOLOGICAL MARKER; ESZOPICLONE; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ACTIMETRY; ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; INSOMNIA SEVERITY INDEX; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONOTHERAPY; OPEN STUDY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SECONDARY ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; ANALYSIS OF VARIANCE; COMPLICATION; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; REST; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BIOMARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REST; SEROTONIN UPTAKE INHIBITORS; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 84928205462     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.02.023     Document Type: Article

References (31)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
2. Bastien C.H., Vallieres A., Morin C.M. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2001, 2:297-307.
3. Bennabi D., Aouizerate B., El-Hage W., Doumy O., Moliere F., Courtet P., et al. Risk factors for treatment resistance in unipolar depression: a systematic review. JAffect Disord 2015, 171:137-141.
4. Castanho A., Bothorel B., Seguin L., Mocaer E., Pevet P. Like melatonin, agomelatine (S20098) increases the amplitude of oscillations of two clock outputs: melatonin and temperature rhythms. Chronobiol Int 2014, 31:371-381.
5. Chan J.W.Y., Lam S.P., Li S.X., Yu M.W.M., Chan N.Y., Zhang Jihui, et al. Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder. Sleep 2014, 37:911-917.
6. Courtet P., Olie E. Circadian dimension and severity of depression. Eur Neuropsychopharmacol 2012, 22:S476-S481.
7. Cuthbert B., Insel T. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013, 11:126.
8. De Berardis D., Marini S., Fornaro M., Srinivasan V., Iasevoli F., Tomasetti C., et al. The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int J Mol Sci 2013, 14:12458-12483.
9. Ding J., Symanzik J., Sharif A., Wang P., Duntley S., Shannon W. Powerful actigraphy data through functional representation. Chance 2012, [in press].
10. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
11. Hamilton M. Arating scale for depression. JNeurol Neurosurg Psychiatry 1960, 23:56-62.
12. Insel T.R. The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry. Am J Psychiatry 2014, 171:395-397.
13. Kapur S., Phillips A.I.T.R. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?. Mol Psychiatry 2012, 17:1174-1179.
14. Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., et al. CLOCK may predict the response to fluvoxamine treatment in Japanese Major Depressive Disorder patients. Neuromol Med 2009, 11:53-57.
15. Kripke D.F., Nievergelt C.M., Joo E., Shekhtman T., Kelsoe J.R. Circadian polymorphisms associated with affective disorders. JCircadian Rhythms 2009, 7:2.
16. Kubitz N., Mehra M., Potluri R.C., Garg N., Cossrow N. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial cliams database. PLoS One 2013, 8:e76882.
17. Kupfer D.J., Foster F.G. Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet September 30 1972, 684-686.
18. Lewy A. Melatonin and human chonobiology. Cold Spring Harbor Symposium on Quantitative Biology 2007, 72:623-636.
19. Maglione J.E., Ancoli-Israel S., Peters K.W., Paudel M.L., Yaffe K., Ensrud K.E., et al. Depressive symptoms and circadian activity rhythm disturbances in community-dwelling older women. Am J Geriatr Psychiatry 2014, 22:349-361.
20. Marler M., Gehrman P., Martin J., Ancoli-Israel S. The sigmoidaly transformed cosine curve: a mathematical model for circadian rhythms with a symmetric non-sinusoidal shapes. Stat Med 2006, 25:3893-3904.
21. McCall W.V., Blocker J.N., D'Agostino R.B., Kimball J., Boggs N., Lasater B., et al. Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression. JClin Sleep Med 2010, 6:322-329.
22. Moore R. The suprachiasmatic nucleus and the circadian timing system. Prog Mol Biol Transl Sci 2013, 119:1-28.
23. Nomura K., Castanon-Cervantes O., Davidson A., Fukuhara C. Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period-1-driven circadian bioluminescence rhythms in rat-1 fibroblasts. Life Sci 2008, 82:1169-1174.
24. R Development Core Team R: a language and environment for statistical computing 2008, R Foundation for Statistical Computing. http://cran.r-project.org/doc/manuals/fullrefman.pdf.
25. Ramsey J., Silverman B. Functional data analysis 2005, Springer, New York.
26. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006, 163:1905-1917.
27. Srinivasan V., Zakaria R., Othman Z., Lauterbach E., Acuna-Castroviejo D. Agomelatine in depressive disorders: its novel mechanism of action. JNeuropsychiatry Clin Neurosci 2012, 24:290-308.
28. Steiger A., Kimura M. Wake and sleep EEG provide biomarkers in depression. JPsychiatric Res 2010, 44:242-252.
29. Symanzik J., Shannon W. Exploratory graphics for functional actigraphy data. Proceedings, American statistical association 2008.
30. Winkler D., Pjrek E., Lanzenberger R., Baldinger P., Eitel D., Kasper S., et al. Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy. JPsychiatr Res 2014, 57:96-100.
31. Xian H., Gonzales C., Deych E., Shannon W., Farris S., Ding J., et al. Age-related effects on circadian phase in the sleep of patients with depression and insomnia. Behav Sleep Med 2014, 10.1080/15402002.2013.855213.